Answers are grounded in this paper and cite their sources.
OBJECTIVES: Pre-death grief has been increasingly recognized as a core component of the Alzheimer's disease and related dementias (ADRD) caregiving experience. This Stage I randomized controlled trial aimed to evaluate the effects of the 8-week Chronic Grief Management Intervention-Video (CGMI-V) on family caregivers' chronic grief and mental health outcomes (e.g. depressive and anxiety symptoms, and positive states of mind) after they placed their care recipients with ADRD in long-term care facilities. METHODS: Participants were randomly assigned to either the CGMI-V intervention condition or the minimal treatment (MT) condition and completed assessments at baseline, week 8 (immediately post-intervention), and week 24 (follow-up). We used standardized measures to assess participants' chronic grief levels, depressive and anxiety symptoms, and positive states of mind. All statistical analyses were conducted on an intent-to-treat basis, using linear mixed models. RESULTS: Our study period largely overlapped with the COVID-19 pandemic. From baseline to 24 wk, compared with caregivers in the MT condition, caregivers in the CGMI-V condition demonstrated a trend toward greater reductions in grief levels, a notable decrease in depressive and anxiety symptoms, and a notable increase in positive states of mind. CONCLUSIONS: CGMI-V is a promising intervention in support of ADRD family caregivers' chronic grief and mental health after placement in long-term care facilities.
No takes yet. Share an insight, caveat, or question.
Paun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: